• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[国际泌尿病理学会（ISUP）2014年前列腺癌Gleason分级共识会议]

[The 2014 consensus conference of the ISUP on Gleason grading of prostatic carcinoma].

作者信息

Kristiansen G, Egevad L, Amin M, Delahunt B, Srigley J R, Humphrey P A, Epstein J I

机构信息

Institut für Pathologie, Universitätsklinikum Bonn, Sigmund-Freud-Str. 25, Gebäude 329, 53127, Bonn, Deutschland.

Department of Oncology-Pathology, Karolinska Universitetssjukhuset Solna, Stockholm, Schweden.

出版信息

Pathologe. 2016 Feb;37(1):17-26. doi: 10.1007/s00292-015-0136-6.

DOI:10.1007/s00292-015-0136-6
PMID:26809207
Abstract

In 2005 the International Society of Urological Pathology (ISUP) held a concensus conference on Gleason grading in order to bring this grading system up to the current state of contemporary practice; however, it became clear that further modifications on the grading of prostatic carcinoma were necessary. The International Society of Urological Pathology therefore held a further consensus conference in 2014 to clarify these points. This article presents the essential results of the Chicago grading meeting.

摘要

2005年，国际泌尿病理学会（ISUP）召开了一次关于Gleason分级的共识会议，以使该分级系统跟上当代实践的现状；然而，很明显有必要对前列腺癌的分级进行进一步修改。因此，国际泌尿病理学会于2014年召开了另一次共识会议以阐明这些要点。本文介绍了芝加哥分级会议的主要结果。

相似文献

1
[The 2014 consensus conference of the ISUP on Gleason grading of prostatic carcinoma].[国际泌尿病理学会（ISUP）2014年前列腺癌Gleason分级共识会议]
Pathologe. 2016 Feb;37(1):17-26. doi: 10.1007/s00292-015-0136-6.
2
SOCS3 Immunohistochemical Expression Seems to Support the 2005 and 2014 International Society of Urological Pathology (ISUP) Modified Gleason Grading System.SOCS3免疫组化表达似乎支持2005年和2014年国际泌尿病理学会（ISUP）改良的Gleason分级系统。
Prostate. 2017 May;77(6):597-603. doi: 10.1002/pros.23299. Epub 2017 Feb 1.
3
The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System.2014年国际泌尿病理学会（ISUP）前列腺癌Gleason分级共识会议：分级模式的定义及新分级系统的建议
Am J Surg Pathol. 2016 Feb;40(2):244-52. doi: 10.1097/PAS.0000000000000530.
4
Contemporary Gleason Grading of Prostatic Carcinoma: An Update With Discussion on Practical Issues to Implement the 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma.当代前列腺癌的Gleason分级：结合对实施2014年国际泌尿病理学会（ISUP）前列腺癌Gleason分级共识会议实际问题的讨论进行更新
Am J Surg Pathol. 2017 Apr;41(4):e1-e7. doi: 10.1097/PAS.0000000000000820.
5
From Gleason to International Society of Urological Pathology (ISUP) grading of prostate cancer.从前列腺癌的格里森分级到国际泌尿病理学会（ISUP）分级
Scand J Urol. 2016 Oct;50(5):325-9. doi: 10.1080/21681805.2016.1201858. Epub 2016 Jul 14.
6
Controversial issues in Gleason and International Society of Urological Pathology (ISUP) prostate cancer grading: proposed recommendations for international implementation.在格里森（Gleason）和国际泌尿病理学会（ISUP）前列腺癌分级中存在争议的问题：国际实施的建议。
Pathology. 2019 Aug;51(5):463-473. doi: 10.1016/j.pathol.2019.05.001. Epub 2019 Jul 3.
7
International Society of Urological Pathology (ISUP) grading of prostate cancer - An ISUP consensus on contemporary grading.国际泌尿病理学会（ISUP）前列腺癌分级——当代分级的ISUP共识
APMIS. 2016 Jun;124(6):433-5. doi: 10.1111/apm.12533.
8
The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma.2019 年国际泌尿病理学会（ISUP）前列腺癌分级共识会议。
Am J Surg Pathol. 2020 Aug;44(8):e87-e99. doi: 10.1097/PAS.0000000000001497.
9
Prostate cancer glands with cribriform architecture and with glomeruloid features should be considered as Gleason pattern 4 and not pattern 3.具有筛状结构和肾小球样特征的前列腺癌腺管应被视为 Gleason 4 级而非 3 级。
Future Oncol. 2016 Jun;12(12):1431-3. doi: 10.2217/fon-2016-0113. Epub 2016 Mar 30.
10
[Prostate cancer. Part 2: Review of the various tumor grading systems over the years 1966-2015 and future perspectives of the new grading of the International Society of Urological Pathology (ISUP)].[前列腺癌。第2部分：1966 - 2015年期间各种肿瘤分级系统回顾以及国际泌尿病理学会（ISUP）新分级的未来展望]
Pathologe. 2016 Feb;37(1):11-6. doi: 10.1007/s00292-015-0124-x.

引用本文的文献

1
Combination of PI-RADS version 2.1 and amide proton transfer values for the detection of clinically significant prostate cancer.PI-RADS v2.1与酰胺质子转移值联合用于检测具有临床意义的前列腺癌
BMC Cancer. 2025 Jul 30;25(1):1249. doi: 10.1186/s12885-025-14610-1.
2
Integrating multimodal imaging and peritumoral features for enhanced prostate cancer diagnosis: A machine learning approach.整合多模态成像与肿瘤周围特征以增强前列腺癌诊断：一种机器学习方法。
PLoS One. 2025 May 15;20(5):e0323752. doi: 10.1371/journal.pone.0323752. eCollection 2025.
3
Quantitative Evaluation of Apparent Diffusion Coefficient Values, ISUP Grades and Prostate-Specific Antigen Density Values of Potentially Malignant PI-RADS Lesions.

本文引用的文献

1
The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System.2014年国际泌尿病理学会（ISUP）前列腺癌Gleason分级共识会议：分级模式的定义及新分级系统的建议
Am J Surg Pathol. 2016 Feb;40(2):244-52. doi: 10.1097/PAS.0000000000000530.
2
A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score.一种当代前列腺癌分级系统：格里森评分的有效替代方案。
Eur Urol. 2016 Mar;69(3):428-35. doi: 10.1016/j.eururo.2015.06.046. Epub 2015 Jul 10.
3
Prostate Biopsy Specimens With Gleason 3+3=6 and Intraductal Carcinoma: Radical Prostatectomy Findings and Clinical Outcomes.
潜在恶性PI-RADS病变的表观扩散系数值、ISUP分级和前列腺特异性抗原密度值的定量评估
Cancers (Basel). 2023 Oct 28;15(21):5183. doi: 10.3390/cancers15215183.
4
[The long journey from palpation to biopsy : The history of diagnosing prostate cancer].从触诊到活检的漫长历程：前列腺癌的诊断史
Urologe A. 2021 Jul;60(7):943-949. doi: 10.1007/s00120-020-01224-7.
5
Proteomic Characterization of Prostate Cancer to Distinguish Nonmetastasizing and Metastasizing Primary Tumors and Lymph Node Metastases.前列腺癌蛋白质组学特征分析用于鉴别非转移和转移的原发肿瘤及淋巴结转移。
Neoplasia. 2018 Feb;20(2):140-151. doi: 10.1016/j.neo.2017.10.009. Epub 2017 Dec 14.
6
Oligometastases from prostate cancer: local treatment with stereotactic body radiotherapy (SBRT).前列腺癌寡转移：立体定向体部放疗（SBRT）的局部治疗
BMC Cancer. 2017 May 22;17(1):361. doi: 10.1186/s12885-017-3341-2.
7
CD147 and Prostate Cancer: A Systematic Review and Meta-Analysis.CD147与前列腺癌：一项系统综述和荟萃分析
PLoS One. 2016 Sep 29;11(9):e0163678. doi: 10.1371/journal.pone.0163678. eCollection 2016.
8
[Grading of prostate cancer].[前列腺癌的分级]
Pathologe. 2016 Jul;37(4):352-4. doi: 10.1007/s00292-016-0185-5.
Gleason评分3+3=6且伴有导管内癌的前列腺活检标本：根治性前列腺切除术的结果及临床转归
Am J Surg Pathol. 2015 Oct;39(10):1383-9. doi: 10.1097/PAS.0000000000000465.
4
Is there any prognostic impact of intraductal carcinoma of prostate in initial diagnosed aggressively metastatic prostate cancer?在初诊为侵袭性转移性前列腺癌时，前列腺导管内癌是否具有任何预后影响？
Prostate. 2015 Feb 15;75(3):225-32. doi: 10.1002/pros.22906. Epub 2014 Oct 13.
5
Cribriform growth is highly predictive for postoperative metastasis and disease-specific death in Gleason score 7 prostate cancer.筛状生长对 Gleason 评分 7 级前列腺癌的术后转移和疾病特异性死亡具有高度预测性。
Mod Pathol. 2015 Mar;28(3):457-64. doi: 10.1038/modpathol.2014.116. Epub 2014 Sep 5.
6
The association of the cribriform pattern with outcome for prostatic adenocarcinomas.筛状模式与前列腺腺癌预后的关联。
Pathol Res Pract. 2014 Oct;210(10):640-4. doi: 10.1016/j.prp.2014.06.002. Epub 2014 Jun 19.
7
Heterogeneous clinicopathological features of intraductal carcinoma of the prostate: a comparison between "precursor-like" and "regular type" lesions.前列腺导管内癌的异质性临床病理特征：“前体样”与“普通型”病变的比较
Int J Clin Exp Pathol. 2014 Apr 15;7(5):2518-26. eCollection 2014.
8
Significance of the cribriform pattern in prostatic adenocarcinomas.筛状模式在前列腺腺癌中的意义。
Pathol Res Pract. 2014 Sep;210(9):554-7. doi: 10.1016/j.prp.2014.03.003. Epub 2014 Mar 30.
9
Addressing overdiagnosis and overtreatment in cancer: a prescription for change.解决癌症的过度诊断和过度治疗问题：变革的良方。
Lancet Oncol. 2014 May;15(6):e234-42. doi: 10.1016/S1470-2045(13)70598-9.
10
When is prostate cancer really cancer?前列腺癌何时才是真正的癌症？
Urol Clin North Am. 2014 May;41(2):339-46. doi: 10.1016/j.ucl.2014.01.006. Epub 2014 Feb 21.